190 related articles for article (PubMed ID: 23782993)
1. Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study.
El-Fakharany EM; Sánchez L; Al-Mehdar HA; Redwan EM
Virol J; 2013 Jun; 10():199. PubMed ID: 23782993
[TBL] [Abstract][Full Text] [Related]
2. Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus.
Redwan EM; El-Fakharany EM; Uversky VN; Linjawi MH
BMC Complement Altern Med; 2014 Jul; 14():219. PubMed ID: 24993815
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of native and recombinant full-length camel lactoferrin and its N and C lobes on hepatitis C virus infection of Huh7.5 cells.
Liao Y; El-Fakkarany E; Lönnerdal B; Redwan EM
J Med Microbiol; 2012 Mar; 61(Pt 3):375-383. PubMed ID: 22052996
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Exploration of the Anti-HCV Potential of the Synthetic Spacer Peptides Derived from Human, Bovine, and Camel Lactoferrins.
Albar AH; El-Fakharany EM; Almehdar HA; Uversky VN; Redwan EM
Protein Pept Lett; 2017; 24(10):909-921. PubMed ID: 27834141
[TBL] [Abstract][Full Text] [Related]
5. Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7.5 hepatoma.
El-Fakharany EM; Abedelbaky N; Haroun BM; Sánchez L; Redwan NA; Redwan EM
Virol J; 2012 Sep; 9():201. PubMed ID: 22978304
[TBL] [Abstract][Full Text] [Related]
6. Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes.
Redwan el-RM; Tabll A
J Immunoassay Immunochem; 2007; 28(3):267-77. PubMed ID: 17613672
[TBL] [Abstract][Full Text] [Related]
7. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
[TBL] [Abstract][Full Text] [Related]
8. Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytes.
Abe K; Nozaki A; Tamura K; Ikeda M; Naka K; Dansako H; Hoshino HO; Tanaka K; Kato N
Microbiol Immunol; 2007; 51(1):117-25. PubMed ID: 17237607
[TBL] [Abstract][Full Text] [Related]
9. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells.
Ikeda M; Nozaki A; Sugiyama K; Tanaka T; Naganuma A; Tanaka K; Sekihara H; Shimotohno K; Saito M; Kato N
Virus Res; 2000 Jan; 66(1):51-63. PubMed ID: 10653917
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes.
Ikeda M; Sugiyama K; Tanaka T; Tanaka K; Sekihara H; Shimotohno K; Kato N
Biochem Biophys Res Commun; 1998 Apr; 245(2):549-53. PubMed ID: 9571193
[TBL] [Abstract][Full Text] [Related]
11. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
[TBL] [Abstract][Full Text] [Related]
12. Humanized-VH/VHH that inhibit HCV replication by interfering with the virus helicase activity.
Phalaphol A; Thueng-In K; Thanongsaksrikul J; Poungpair O; Bangphoomi K; Sookrung N; Srimanote P; Chaicumpa W
J Virol Methods; 2013 Dec; 194(1-2):289-99. PubMed ID: 24036073
[TBL] [Abstract][Full Text] [Related]
13. Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry.
Hsu WC; Chang SP; Lin LC; Li CL; Richardson CD; Lin CC; Lin LT
Antiviral Res; 2015 Jun; 118():139-47. PubMed ID: 25865056
[TBL] [Abstract][Full Text] [Related]
14. Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein.
Nozaki A; Ikeda M; Naganuma A; Nakamura T; Inudoh M; Tanaka K; Kato N
J Biol Chem; 2003 Mar; 278(12):10162-73. PubMed ID: 12522210
[TBL] [Abstract][Full Text] [Related]
15. Selection of peptides binding to HCV e2 and inhibiting viral infectivity.
Hong HW; Lee SW; Myung H
J Microbiol Biotechnol; 2010 Dec; 20(12):1769-71. PubMed ID: 21193836
[TBL] [Abstract][Full Text] [Related]
16. A reliable internally controlled RT-nested PCR method for the detection of hepatitis C virus RNA.
Nozaki A; Naganuma A; Nakamura T; Tanaka K; Sekihara H; Kato N
Acta Med Okayama; 2000 Dec; 54(6):253-7. PubMed ID: 11132918
[TBL] [Abstract][Full Text] [Related]
17. In vitro infection of immortalized primary hepatocytes by HCV genotype 4a and inhibition of virus replication by cyclosporin.
El-Farrash MA; Aly HH; Watashi K; Hijikata M; Egawa H; Shimotohno K
Microbiol Immunol; 2007; 51(1):127-33. PubMed ID: 17237608
[TBL] [Abstract][Full Text] [Related]
18. The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune Lactoferrin protein.
Picard-Jean F; Bouchard S; Larivée G; Bisaillon M
Antiviral Res; 2014 Nov; 111():13-22. PubMed ID: 25193851
[TBL] [Abstract][Full Text] [Related]
19. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
J Virol; 2019 May; 93(10):. PubMed ID: 30842319
[TBL] [Abstract][Full Text] [Related]
20. Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.
Nakajima S; Watashi K; Ohashi H; Kamisuki S; Izaguirre-Carbonell J; Kwon AT; Suzuki H; Kataoka M; Tsukuda S; Okada M; Moi ML; Takeuchi T; Arita M; Suzuki R; Aizaki H; Kato T; Suzuki T; Hasegawa H; Takasaki T; Sugawara F; Wakita T
J Virol; 2016 Oct; 90(20):9058-74. PubMed ID: 27489280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
